Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease

2004/02/25 by Toshiro Sato, Takanori Kanai∥, Takanori Kanai +13 · 17 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Antibody #Biology #CD28 #CD3 #CD8 #Cytokine #Diabetes and associated disorders #Disease #Epithelium #Flow cytometry #Immune Response and Inflammation #Immune system #Immunology #Inflammation #Inflammatory bowel disease #Lamina propria #Medicine #Monoclonal antibody #Pathology #Peripheral blood mononuclear cell #T cell #T-cell and B-cell Immunology #Ulcerative colitis

paper · pdf · doi:10.1053/j.gastro.2003.12.011

openalex publication_date 2004/02/25 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives
• Upregulation of ICOS on CD43+ CD4+ murine small intestinal intraepithelial lymphocytes during acute reovirus infection. [europepmc]
• T-cell activation in the intestinal mucosa. [europepmc]
• Massive but selective cytokine dysregulation in the colon of IL-10-/- mice revealed by multiplex analysis. [europepmc]
• Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. [europepmc]
• Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele. [europepmc]
• The genomic architecture of mastitis resistance in dairy sheep. [europepmc]
• Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases. [europepmc]
• ICOS + Tregs: A Functional Subset of Tregs in Immune Diseases. [europepmc]
• First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjects. [europepmc]
• Role of endocytosis and trans-endocytosis in ICOS costimulator-induced downmodulation of the ICOS Ligand. [europepmc]
• Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models. [europepmc]
• Protective Effects of Aminooxyacetic Acid on Colitis Induced in Mice with Dextran Sulfate Sodium. [europepmc]
• The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population. [europepmc]
• CD28 and ICOS in immune regulation: Structural insights and therapeutic targeting. [europepmc]
• Surface Plasmon Resonance (SPR)-Based Workflow for High-Throughput Discovery of CD28-Targeted Small Molecules. [europepmc]
• Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives. [europepmc]